Due to their specific role as Antigen Presenting Cells (APCs) and subsequent capacity to stimulate T-cells with antitumor influence, dendritic cell-based therapies have emerged as an exciting avenue of cell-based therapy. Also, recent advances are widely studied and implemented in immune checkpoint inhibitors (ICIs), Adoptive T-cell therapies (ACTs), and human-induced pluripotent stem cells (hiPSCs). Immune […]
